A5069701290- Opioid Use Disorder Treatment
- Substance Abuse Treatment and Outcomes
- Prenatal Substance Exposure Effects
- HIV, Drug Use, Sexual Risk
- Pain Management and Opioid Use
- Poisoning and overdose treatments
- Schizophrenia research and treatment
- Health Policy Implementation Science
- Pharmaceutical Practices and Patient Outcomes
- Patient Satisfaction in Healthcare
- Homelessness and Social Issues
- Child and Adolescent Psychosocial and Emotional Development
- Pediatric Pain Management Techniques
- Cannabis and Cannabinoid Research
- Eating Disorders and Behaviors
- Obsessive-Compulsive Spectrum Disorders
- Primary Care and Health Outcomes
- Forensic Toxicology and Drug Analysis
- Digital Mental Health Interventions
- Cardiac Arrest and Resuscitation
- Mental Health and Patient Involvement
- Neurotransmitter Receptor Influence on Behavior
- Bipolar Disorder and Treatment
- Mental Health Treatment and Access
- Social Media in Health Education
West Virginia University
2017-2024
University of Pittsburgh
2024
Blanchette Rockefeller Neurosciences Institute
2019-2024
National Park Service
2020
University of Cincinnati Medical Center
2009-2017
Reserve Bank of Australia
2017
The University of Sydney
2017
State of Ohio Board of Pharmacy
2017
University of Cincinnati
2014-2017
Johns Hopkins University
2006-2014
An epidemic of drug overdose deaths has led to calls for programs and policies limit misuse diversion opioid medications. Any parallel call consider the risk iatrogenic addiction when treating pain been muted in comparison. We have moved beyond questions nonmedical use, abuse, highlight role prescription opioids causing even prescribed used appropriately. Unfortunately, current evidence is insufficient, a rapid expansion longitudinal research urgently needed guide clinicians balancing need...
To describe the strategies and policies implemented in Ohio to improve opioid safety discuss role that pharmacists can play implementing, promoting, enhancing effectiveness of these policies.
Opioid dependence is an increasing problem among adolescents and young adults, but in contrast to the standard adult population, adoption of pharmacotherapies has been slow. Extended-release naltrexone (XR-NTX) a promising treatment that receiving interest for opioid dependence. Clinical chart abstractions were performed on convenience sample 16 serial adolescent cases (mean age 18.5 years) treated with XR-NTX who attended at least one out-patient clinical follow-up visit.Of these cases, 10...
Abstract Objective: This study evaluated duloxetine in the treatment of binge eating disorder (BED) with comorbid current depressive disorders. Method: In this 12‐week, double‐blind, placebo‐controlled trial, 40 patients Diagnostic and Statistical Manual Mental Disorders‐IV‐TR BED a received ( N = 20) or placebo 20). The primary outcome measure was weekly day frequency. Results: analysis, (mean 78.7 mg/day) superior to reducing frequency days p .04), episodes .02), weight Clinical Global...
Nationally, overdose fatalities have reached epidemic proportions. Ohio has one of the highest death rates in country, as well high prescription opioid trafficking.A cross-sectional self-report survey prevention programs (OOPPs) was conducted between August and October 2014 to characterize ascertain barriers successful implementation. A 91% response rate achieved with 18 participating study.The first OOPP opened 2012, a second program 2013, remaining began 2014. All distribute nasal naloxone...
Rising overdose fatalities among U.S. veterans suggest taking prescription opioids may be at risk for overdose. However, it is unclear whether prescribed chronic are aware of this risk. The objective study was to identify factors and determine awareness opioid in treated with pain, using methadone or buprenorphine use disorder as a high-risk comparator group. In the current study, 90 on medication, either pain management, completed questionnaire assessing factors, knowledge, self-estimate...
This study evaluated the efficacy and tolerability of ramelteon in ambulatory bipolar I disorder with manic symptoms insomnia. Twenty-one outpatients by Diagnostic Statistical Manual Mental Disorders, fourth edition criteria mild-to-moderate sleep disturbance were randomized to receive either (N=10) or placebo (N=11) an 8-week, double-blind, fixed-dose (8 mg/day) study. Ramelteon had similar rates reduction ratings insomnia, mania, global severity illness. However, was associated improvement...
Abstract Objective: To assess preliminarily the effectiveness of acamprosate in binge eating disorder (BED). Method: In this 10‐week, randomized, placebo‐controlled, flexible dose trial, 40 outpatients with BED received ( N = 20) or placebo 20). The primary outcome measure was episode frequency. Results: While not associated a significantly greater rate reduction frequency any other longitudinal analysis, endpoint analysis it statistically significant improvements day and measures...
Weight gain is commonly observed with olanzapine treatment. Zonisamide an antiepileptic drug associated weight loss. This study examined the effectiveness of zonisamide in preventing 42 patients beginning for bipolar disorder or schizophrenia. Each patient had a body mass index 22 mg/kg2 greater and was randomized to taking either (n = 20) placebo 22) 16 weeks. The primary outcome measure change kilograms from baseline. In analysis using longitudinal regression, who received significantly...
Abstract The purpose of this study is to identify factors associated with adolescent alcohol or drug (AOD) abuse/dependence, mental health and co-occurring problems, as well access treatment. This a secondary analysis data from the National Survey on Drug Use Health (NSDUH) 2000. 12-month prevalence rate adolescents only problems was 10.8%, 5.1% had AOD abuse/dependence only, 2.7% problems. Approximately 15% youths reported receiving behavioral treatment in past 12 months. Several having are...